Light chain (AL) Amyloidosis/Primary
Apr 27, 2024
When:
Saturday, April 27, 2024
AL will meet in the AM-Registration: 8:00-8:30AM
ATTR will meet in the PM-Registration: 11:30-12:30PM
Where:
Goldberg Auditorium…
Apr 20, 2024
When:
Saturday, April 20, 2024
AL will meet in the AM-Registration: 8:00-8:30AM
ATTR will meet in the PM-Registration: 11:30-12:30PM
Where:
Rood Pavilion…
Apr 20, 2024
When:
Saturday, April 20, 2024
AL will meet in the AM-Registration: 8:30-9:00AM
ATTR will meet in the PM-Registration: 11:30-12:30PM
Where:
Reform Congregation…
Apr 20, 2024
If you are from Kansas, Nebraska, Missouri, Iowa, Arkansas, Oklahoma, or anywhere else, know you are welcome.
When:
Saturday, April 20, 2024
AL will meet in the…
Sep 09, 2023
This Meeting Is for AL Amyloidosis Only
When:
Saturday, September 9, 2023 | 9:00 am - 2:00 pm
Registration: 8:00 am - 9:00 am
Meeting: 9:00 - 2:00 pm
Lunch: 12:00…
Aug 03, 2021
The recent decades have ushered in considerable advancements in the diagnosis and treatment of systemic light chain (AL) amyloidosis. As disease outcomes improve,…
Jan 06, 2021
The International Society of Amyloidosis (ISA)external link, opens in a new tab developed criteria for assessing the haematologic response to treatment in light…
Sep 13, 2020
Systemic amyloidosis is a rare protein misfolding and deposition disorder leading to progressive organ failure. There are over 15 types of systemic amyloidosis,…
Jul 06, 2020
Importance: Many patients with systemic amyloidosis are underdiagnosed. Overall, 25% of patients with immunoglobulin light chain (AL) amyloidosis die within 6…
Apr 29, 2020
Daratumumab is a human monoclonal antibody targeting CD38, an antigen uniformly expressed by plasma cells in multiple myeloma and light-chain amyloidosis (AL). We…